Chargement de la fiche…
rhumatologie
Dr Alice Tison
Praticien hospitalier
Brest (29609)
Cancer Immunotherapy and Biomarkers · Salivary Gland Disorders and Functions · Rheumatoid Arthritis Research and Therapies
0Publications
0Citations
Publications actives
Côté patient
Avant votre rendez-vous avec le Dr Alice Tison
Choisissez votre pathologie pour une explication en langage simple.
Parcourir toutes les pathologies →Des applications évaluées par MonRhumato, sélectionnées pour les patients.
MapathoPlateforme communautaire maladies chroniques + annuaire pair-validé
GustaveAgent IA souverain pour information patient sourcée
Remedee LabsBracelet stimulateur d'endorphines pour douleur chroniquePourquoi consulter Dr Alice Tison
- Auteur de référence en rhumatologie
- Référence presse grand public
- Délais de RDV courts dans la région
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Parcours
2025–2026
Hospital for Special Surgery
2021–2026
Inserm
2021–2026
Université de Bretagne Occidentale
2017–2026
Centre Hospitalier Régional Universitaire de Brest
2025
Laboratoire National de Référence
2021
Université de Bordeaux
Rayonnement scientifique
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 11 articles cités au moins 11fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Dernières publications
Diplômes & qualifications
DES
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
CES
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
Lieu d'exercice
Domaines d'expertise
Cancer Immunotherapy and BiomarkersSalivary Gland Disorders and FunctionsRheumatoid Arthritis Research and TherapiesVasculitis and related conditionsColorectal Cancer Treatments and Studies
Bibliométrie (OpenAlex)
Profil ↗0
travaux
0
h-index
0
i10-index
0
citations
Cancer Immunotherapy and BiomarkersSalivary Gland Disorders and FunctionsRheumatoid Arthritis Research and TherapiesVasculitis and related conditionsColorectal Cancer Treatments and Studies
Transversal
132026The Journal of investigative dermatology
PubMed ↗B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non-drug-related lichen planus
2026The Journal of rheumatology
PubMed ↗Spondylodiscitis Caused by Tropheryma whipplei: Report of 2 Cases
2026Joint bone spine
PubMed ↗Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica
2025The Lancet. Rheumatology
PubMed ↗What can imaging teach us about immune checkpoint inhibitor-induced arthritis?
2024Rheumatic diseases clinics of North America
PubMed ↗Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica
2024RMD open
PubMed ↗Detection of hypophosphatasia in hospitalised adults in rheumatology and internal medicine departments: a multicentre study over 10 years
2023RMD open
PubMed ↗Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
2022Nature reviews. Rheumatology
PubMed ↗Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
2021European journal of cancer (Oxford, England : 1990)
PubMed ↗Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
2021Scientific reports
PubMed ↗Publisher Correction: Rheumatological features of Whipple disease
2021Scientific reports
PubMed ↗Rheumatological features of Whipple disease
2020Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Reply
2019Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
PubMed ↗Potential Role for Urine Polymerase Chain Reaction in the Diagnosis of Whipple Disease
Épidémiologie & registres
42026Journal for immunotherapy of cancer
PubMed ↗Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
2026Annals of the rheumatic diseases
PubMed ↗Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
2025Rheumatology and therapy
PubMed ↗Prevalence and Significance of the Presence of Anti-transglutaminase and Anti-endomysium Antibodies in Patients with Early Inflammatory Joint Disease
2019Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study
Revue générale
32026Joint bone spine
PubMed ↗Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review
2022Joint bone spine
PubMed ↗Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis
2018Expert review of anticancer therapy
PubMed ↗Immune-checkpoint inhibitors to treat cancers in specific immunocompromised populations: a critical review
Sjögren
32025Rheumatology (Oxford, England)
PubMed ↗Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study
2024Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation
2021Rheumatology (Oxford, England)
PubMed ↗B cells in Sjögren's syndrome: from pathophysiology to therapeutic target
Biothérapies non-anti-TNF
22024European journal of nuclear medicine and molecular imaging
PubMed ↗[(18)F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
2023The Lancet. Rheumatology
PubMed ↗Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
Corticothérapie
12026Annals of the rheumatic diseases
PubMed ↗Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
JAK inhibiteurs
12025The Lancet. Rheumatology
PubMed ↗Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
Pharmacovigilance
12019Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study
Revue / méta-analyse
12022Joint bone spine
PubMed ↗Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis
Publications HAL
82026Article
Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica
Joint Bone Spine
2026Article
Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review
Joint Bone Spine
2025Article
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
The Lancet Rheumatology
2025Article
Prevalence and Significance of the Presence of Anti-transglutaminase and Anti-endomysium Antibodies in Patients with Early Inflammatory Joint Disease
Rheumatology and Therapy
2024Article
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study
Rheumatology
2024Article
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica
Rheumatic Disease Clinics of North America
2024Article
Detection of hypophosphatasia in hospitalised adults in rheumatology and internal medicine departments: a multicentre study over 10 years
RMD Open : Rheumatic & Musculoskeletal Diseases
2024Article
Association of Combined Anti‐Ro52 / TRIM21 and Anti‐Ro60 / SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation
Arthritis & rheumatology
Presse
2Université de Bretagne Occidentale (UBO, Brest)
Prix et distinctions | Lymphocytes B, Autoimmunité et Immunothérapies - UMR 1227 - Université de Bretagne Occidentale (UBO, Brest)
<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9iaGhIUW1nZ2ZnSXVGcjRVZE9oV3N0ck0yNmk1cXRXMVBhWWpYaEJEVHJCQUZEbEFYcVB0SEs3YnVNVUtuRmRKOUkta0xoNUJOeFdDOXE1ME1ROHJxU3J3ckVYRS1Cdm1lTlRR?oc=5" target="_blank">Prix et distinctions | Lymphocytes B, Autoimmunité et Immunothérapies - UMR 1227</a
Le Télégramme
Jeunes chercheurs. Les trois lauréats 2018 - Le Télégramme
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQZzNPbnNuR0c2bW5iM3c1TjVXbXRxYzRVQzdkWDBpbGx6NGpNelMwWEhhbGJaYWRBS2dUS1RxUGpycFpSak5FWk1laGh2eWdwY213a3pIU01hdnhoaTJDRzNPd1prR1hRaE5kdDVmTTlmU2NpX3Y3eFRBdVVZNjJaQ0o5ZndzSVk4MWExS3ZGbDRIU2FBdnZHTTdyNUJ1RTVNaGxSZUN1NWIzVEZfaFFzMg?oc=5" targe
Rhumatologues à proximité
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.